Problem
Corporate crime in the pharmaceutical industry
Nature:
The fragmented hierarchy of a large international drug company, with separate management structures in marketing, research, and administration, make the identification of fraud or misconduct extremely difficult.
Background:
Making prescription drugs is big business. In 1974 the world drugs market was worth $12 billion a year, in 1994 it is close to $300 billion. Stock market capitalization of the drugs industry had doubled in the decade to 1994, and earnings have been growing at a rate of 15 to 20 percent a year.
Broader Problems:
Corporate crimeUnethical pharmaceutical practices Narrower Problems:
Counterfeit drugsChemical trespassIrresponsible pharmaceutical advertising Related Problems:
Drug-related crimeCorporate human rights crimes Strategies:
Reforming pharmaceutical usage in public health Values:
CrimeUncorporate Subject(s):
Commerce → Business enterprises??Health Care → Pharmacy??
Industry → Industry ??
Societal Problems → Crime??
Related UN Sustainable Development Goals:
Problem Type:
E: Emanations of other problems Date of last update
25.09.2019 – 16:55 CEST